CLINICAL_TRIALS
trial_result
· 2019-05-17
Clinical Trial Update: Antithrombin Supplementation in ECMO [Phase 2, Phase 3]
Summary
A Phase 2/Phase 3 clinical trial evaluating antithrombin supplementation in patients undergoing extracorporeal membrane oxygenation has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Policlinico Hospital | Conditions: Extracorporeal Membrane Oxygenation | Phase 2, Phase 3 | Status: COMPLETED